Pfizer’s antiviral oral drug Paxlovid that was developed as an early treatment for Covid-19 can cause severe or life-threatening effects if it is taken in tandem with other common medications including some anticoagulants, anti-depressants, and cholesterol-lowering drugs that are used widely across the US, according to a warning from the Food and Drug Administration (FDA).
There are six pages of warnings with this drug.
In addition to the potentially dangerous drug combinations, the agency does not recommend that individuals with kidney or liver disease take the new drug because it could also cause complications.
Pfizer’s Covid pill regiment – Paxlovid – consists of a mix of two drugs – one being nirmatrelvir, which is meant to stop the SARS-CoV-2 virus from replicating, and the second, ritonavir, is an agent that acts to prolong the duration of the first.
Like Pfizer’s Covid vaccine, the experimental drug has only been granted an Emergency Use Authorization (EUA) by the FDA.
The FDA granted Paxlovid its EUA just one month after Brandon’s regime announced that it would be purchasing 10 million courses of the drug.
Paxlovid was the first antiviral oral medication of its kind that has been authorized for the treatment of Covid-19 even though other – more cost-effective – treatments have been proven to work and are widely available.
One such example of these cheap and safe treatments – Ivermectin – has not been approved in any capacity by the FDA to treat Covid-19, despite its strong results against the virus.
In fact, the US public health experts have refused to conduct any sort of large-scale clinical testing of Ivermectin’s effectiveness against Covid-19 throughout the pandemic in order to maintain plausible deniability that the treatment does not work against the China-virus.
Conveniently, this allows them to spend countless taxpayer dollars on the development and purchase of these more expensive treatments that haven’t even been proven to be safe, let alone effective.
But that hasn’t stopped other countries and entities from running clinical trials of their own to prove Ivermectin is a viable option to treat Covid. No surprise, the results show a sharp improvement in the prognosis of patients who have been diagnosed with Covid once Ivermectin is introduced.
Pfizer will begin delivery of its highly-profitable new drug immediately upon the start of 2022, continuing through the remainder of the year. The 10 million packs of Paxlovid will undoubtedly be just the starting point for the fraudulent Brandon regime as they look to capitalize further on this manufactured pandemic.
Earlier in December, Pfizer announced that the pill is able to reduce the risk of hospitalization or death from the Covid-19 by as much as 89 percent when taken shortly after initial symptoms.
It’s no wonder that HHS Secretary Xavier Becerra emphasized the importance of “getting vaccinated” even when Paxlovid becomes available.
“Getting vaccinated remains the most important action anyone can take to help protect themselves and others and end this pandemic, but for people who do get sick in the future and are at risk of severe outcomes, having pills they can take to keep them out of the hospital could be a lifesaver,” Becerra stated.
“This agreement would help ensure millions of doses of this drug would be available to the American people if it is authorized.”